Company: ACBM
Filing Date: 2025-07-24
Form Type: 10-Q
Source: 0001640334-25-001302
Chunk: 0

Company: ACRO BIOMEDICAL CO., LTD.
Filing Date: 2025-07-24
Form: 10-Q
Item: Item 1
Chunk 0
---
ACRO BIOMEDICAL CO., LTD.

Balance Sheets

(Unaudited)

  March 31,  December 31,   2025  2024        ASSETS      Current Assets      Cash $251  $476 Security deposit  4,600   4,600 Total Current Assets  4,851   5,076          Operating lease right of use asset  20,324   26,898 TOTAL ASSETS $25,175  $31,974          LIABILITIES AND STOCKHOLDERS’ DEFICIT                 Current Liabilities        Accounts payable and accrued expenses $143,178  $154,460 Deferred revenue  20,000   20,000 Due to related parties  147,894   125,588 Operating lease liabilities - current  18,009   26,898 Total Current Liabilities 329,081  326,946          Stockholders’ Deficit        Preferred stock: 25,000,000 authorized; $0.001 par value; no shares issued and outstanding  -   - Common stock: 100,000,000 authorized; $0.001 par value; 60,042,000 shares issued and outstanding  60,042   60,042 Additional paid-in capital  32,304,148   32,302,781 Accumulated deficit  (32,668,096)  (32,657,795)Total Stockholders’ Deficit  (303,906)  (294,972)         TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT $25,175  $31,974 

The accompanying notes are an integral part of these unaudited financial statements.

 4Table of Contents

ACRO BIOMEDICAL CO., LTD.

Statements of Operations

(Unaudited)

  Three months ended   March 31,   2025  2024        Revenues $-  $-          Operating expenses        Selling, general and administrative  8,934   10,298 Total operating expenses  8,934   10,298          Loss from operations  (8,934)  (10,298)         Other